• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Progenics Pharmaceuticals

Progenics Pharmaceuticals

Progenics Pharmaceuticals Inc PGNX

Last Price$7.06Day Change (%)-2.62%
Open Price$7.18Day Change ($)-0.19
Day Range7.01–7.4252-Week Range3.10–7.57

As of Mon 12/22/2014 12:13 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. More Than 150 Companies Expected to Present at the 17th Annual BIO CEO & Investor Conference

    More Than 150 Companies Expected to Present at the 17th Annual BIO CEO & Investor Conference

  2. Investor or Speculator?

    Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...

  3. It’s Never Too Early: Roth 401(k)s and Other Fun Stuff

    Progenics Pharmaceuticals PGNX announced on March 6 that it would backtrack and reformulate the oral version opioid bowel dysfunction drug MNTX to make it more effective. If successful, the firm could file for its approval in late 2009. Our fair value estimate remains unchanged, as we'd already ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.